ClinConnect ClinConnect Logo
Search / Trial NCT06072274

Efficacy of VR Educational Program on Empathy and Attitudes Toward Dementia in Caregivers

Launched by TAIPEI MEDICAL UNIVERSITY · Oct 2, 2023

Trial Information

Current as of October 25, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how a virtual reality (VR) educational program can help caregivers of people with dementia better understand and empathize with their loved ones. The goal is to see if this innovative approach can change caregivers’ attitudes toward dementia and improve their ability to connect with those they care for. The study will include about 600 participants who will be randomly placed in one of two groups: one group will experience the VR program, which lasts about 2-3 hours, while the other group will not.

To participate, individuals need to be over 20 years old, speak Chinese, and currently care for someone with dementia. However, those who cannot safely use VR devices or have a strong dislike or fear of them will not be eligible. Participants can expect to fill out questionnaires before and after the program to help researchers understand any changes in their feelings and attitudes toward dementia care. This study is not yet recruiting, but it aims to shed light on the potential benefits of using technology to support caregivers in their important roles.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Over 20 years;
  • 2. Speak Chinese;
  • 3. Take care of people with dementia currently.
  • Exclusion Criteria:
  • 1. Those who are unable to use VR devices due to certain physical or mental situations;
  • 2. Those who have fear/disgust for VR devices;
  • 3. Those who feel dizzy after using VR devices;
  • 4. The individual with dementia is currently residing in a care facility.

About Taipei Medical University

Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.

Locations

Patients applied

0 patients applied

Trial Officials

Dorothy Bai, PhD

Principal Investigator

Taipei Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported